MSFT three-lens brief
Evidence-based stock research on MSFT. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
50-day MA below 200-day MA (death-cross regime); price below both.
- 50-day MA below 200-day MA (death-cross regime); price below both.
- Analyst mean target $559.93 — 46% above current (55 analysts).
- Earnings scheduled 2026-07-29.
MSFT closed at $384.02 (-0.09%) as of 2026-07-10. Market cap: $2.85T. P/E (trailing) 22.9. Price is below the 50-day MA and below the 200-day MA. Positives: analyst mean target $559.93 — 46% above current (55 analysts).. Concerns: 50-day MA below 200-day MA (death-cross regime); price below both.. Last quarter: Revenue $82.89B, net income $31.78B, free cash flow $37.01B. Watching for: 2026-07-29 earnings release (18 days out).
Why three lenses on MSFT, not one.
A single reasoning model has blind spots it doesn’t know about. We examine MSFTacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/MSFT" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath MSFT brief"></iframe>